CTT on Renogram as an Early Marker of Significant Obstruction in Uretero-pelvic Junction Syndrome
Recruiting
N/A
Interventional Study
Ureteropelvic Junction Obstruction
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 4 Weeks – 8 Weeks
- Sex
- Any
- Study type
- Interventional
- Purpose
- Diagnostic
- Participants needed
- 75 (estimated)
- Sponsor
- Centre Hospitalier Universitaire de la Réunion · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Cortical transit time on diuretic renogram as an early marker of significant obstruction in antenatally detected uretero-pelvic junction syndrome
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
Infants:
* Aged of 4 to 8 weeks of life
* Presenting an ureteropelvic junction obstruction (UPJO) detected before birth by ultrasound
* Presenting an UPJO, defined by an Antero-Posterior Renal Pelvic Diameter greater or equal to 15 mm, confirmed by ultrasound post-natally betwe…
Contacts